NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Study enrolling adults with mild to moderate COVID-19 in the United States.
NIAID
NIH?Turning Discovery Into Health?
Adults interested in participating in the trial should email?actg.communications@fstrf.org(link sends e-mail).